Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Identification of gene fusion transcripts and isoform variants with applications to breast cancer

FY 2009-10

Summary
A major goal in genetics is to unravel the genetic sequence (DNA) of individual genomes, which store the biological blueprint for a living organism in regions called genes. Although the decoding of DNA, called sequencing, has been used over the past decade, the process was costly and cumbersome to perform. New technological improvements have made sequencing much faster and cheaper that will revolutionize the way scientists study genetics. During cell division, rearrangements called translocations can occur such that a segment of DNA from one gene gets transported and replaces a segment of another gene. This results in the creation of a new gene fusion protein product whose function, when expressed, is typically detrimental. Recent studies have shown that certain gene fusions may represent hallmarks of cancer as they are uniquely present in the tumour cell. Some examples have been identified in cancers of the blood (chronic myelogenous leukemia), lung, prostate and breast. Using these new sequencing technologies, it is now possible to examine these "mixed" protein products at a high level of resolution. In this project, breast cancer samples will be sequenced and methodologies will be developed for the characterization of gene fusions. We also wish to investigate whether gene fusions have a role in differentiating between breast cancer samples derived from the same origin but in biologically distinct states. For example, cancer cells from the primary tumour site may have marked differences when compared to those that have spread, or metastasised, to another location. Breast cancer is the second leading cause of cancer-related deaths and the most frequently diagnosed cancer among Canadian women, according to the 2008 statistics reported by the Canadian Cancer Society. Therefore, our goal is to provide insight into the role of gene fusions in breast cancer, where clinical applications for diagnosis or treatment may potentially be developed based on this knowledge.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
206128
Name
Ha Kevin C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification of gene fusion transcripts and isoform variants with applications to breast cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer; Gene Expression; Gene Fusions; Genomics; High-Throughput Sequencing; Splicing Regulation; Transcriptome Analysis
Abstract
A major goal in genetics is to unravel the genetic sequence (DNA) of individual genomes, which store the biological blueprint for a living organism in regions called genes. Although the decoding of DNA, called sequencing, has been used over the past decade, the process was costly and cumbersome to perform. New technological improvements have made sequencing much faster and cheaper that will revolutionize the way scientists study genetics. During cell division, rearrangements called translocations can occur such that a segment of DNA from one gene gets transported and replaces a segment of another gene. This results in the creation of a new gene fusion protein product whose function, when expressed, is typically detrimental. Recent studies have shown that certain gene fusions may represent hallmarks of cancer as they are uniquely present in the tumour cell. Some examples have been identified in cancers of the blood (chronic myelogenous leukemia), lung, prostate and breast. Using these new sequencing technologies, it is now possible to examine these "mixed" protein products at a high level of resolution. In this project, breast cancer samples will be sequenced and methodologies will be developed for the characterization of gene fusions. We also wish to investigate whether gene fusions have a role in differentiating between breast cancer samples derived from the same origin but in biologically distinct states. For example, cancer cells from the primary tumour site may have marked differences when compared to those that have spread, or metastasised, to another location. Breast cancer is the second leading cause of cancer-related deaths and the most frequently diagnosed cancer among Canadian women, according to the 2008 statistics reported by the Canadian Cancer Society. Therefore, our goal is to provide insight into the role of gene fusions in breast cancer, where clinical applications for diagnosis or treatment may potentially be developed based on this knowledge.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ha, Kevin C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2009-10) | Canada Spends